Formulary Management for Topical Acne and Rosacea Agents August 2016
Executive Summary
This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.
Learn more about the Freedom of Information Act (FOIA) Reading Room, which is part of the 1996 amendments to FOIA, mandating publicly accessible "electronic reading rooms" with agency FOIA response materials and other information routinely available to the public.
Please note that files more than five years old may not be compliant with Section 508 of the Rehabilitation Act. If you need an accessible version of a particular file, please contact us and we will provide one for you.
We found 715 items
Executive Summary
Approved Laboratory Developed Tests by Test Name or by Gene(s) Tested
This fact sheet provides the dosing schedule for MMR, Varicella, Hepatitis A and Hepatitis B vaccines.
Formulary Management RFQ from the November 2016 P&T Committee Meeting
Personally Identifiable Information (PII), Protected Health Information (PHI), and Federal Information Requirements
Formulary Management documents from the November 2016 P&T Committee Meeting
Formulary Management documents from the November 2016 P&T Committee Meeting
Meeting Minutes from August 23, 2016 Pre-Proposal Teleconference.
Formulary Management documents from the November 2016 P&T Committee Meeting
Formulary Management documents from the May 2016 P&T Committee Meeting
Formulary Management documents from the May 2016 P&T Committee Meeting
Formulary Management documents from the May 2016 P&T Committee Meeting
This fact sheet educates beneficiaries about how they can protect the health care information under their control.
This Information Paper provides an overview of Privacy Impact Assessment (PIA).
This fact sheet is an overview of accepted practices for rehabilitation strategies for visual field loss and is intended to assist all who provide eye care and rehabilitation to individuals with visual field loss caused by traumatic or acquired brain injury.
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil View the external links disclaimer.